• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Fresenius’ NxStage launches Speedswap for critical care dialysis

Fresenius’ NxStage launches Speedswap for critical care dialysis

August 25, 2022 By Sean Whooley

Fresenius Medical CareFresenius Medical Care North America’s renal therapies group announced today that it launched the Speedswap for the NxStage System One with NxView.

Speedswap, a new option for the NxStage System One with NxView, enables the changing of a flow-compromised dialysis filter without replacing the entire cartridge.

According to a news release, Fresenius designed the new Speedswap system to help reduce therapy downtime, ease nursing workloads and lower treatment costs in acute care settings by improving the filter change through the use of a pre-attached, yet detachable, filter that allows for the replacement without replacing a cartridge.

“This introduction of Speedswap aims to both improve the quality of dialysis treatment in the critical care setting and make our technology even easier to use by the care team,” said Joe Turk, president of the Renal Therapies Group at Fresenius Medical Care North America. “This product is another example of how we are always working to introduce innovations that improve our NxStage System One and ensure it remains the first and best choice of all hospitals for continuous therapy.”

Fresenius said the system brings two products to the market for use with NxStage System One with NxView in the form of Cartridge Express with Speedswap and the Speedswap Express Kit. The Speedswap system includes shipping connectors for maintaining sterility and integrity of valves, which enable the user to disconnect the pre-attached filter.

Speedswap also offers a line restrictor for pressure adjustment within venous and arterial lines, a “Safe2” rotator connector to prevent accidental disconnect and improve handling, pressure-oscillating diaphragm (POD) technology for eliminating the blood-air interface and needleless vales for minimizing the occurrence of air in the circuit.

The NxStage System One with NxView features a volumetric fluid balancing system that allows for fluid accuracy without the need for scales.

“The simplified filter exchange should help make our life-sustaining therapy even easier to provide in an often busy critical care setting,” said Dr. Mike Anger, CMO for FMCNA’s Renal Therapies Group. “We also hope to improve patient outcomes by reducing the time necessary to change dialysis filters which should minimize interruption to continuous kidney replacement therapy.”

Filed Under: Business/Financial News, Dialysis Tagged With: Fresenius Medical Care, NxStage Medical Inc.

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy